Bucur Julian, Werner Liliana, Kohnen Thomas
Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany.
John A. Moran Eye Center, Intermountain Ocular Research Center, University of Utah, Salt Lake City, USA.
Am J Ophthalmol Case Rep. 2024 Jul 21;36:102129. doi: 10.1016/j.ajoc.2024.102129. eCollection 2024 Dec.
The IC-8® Apthera™ (AcuFocus Inc.™, Irvine, California, USA) is the first small aperture intraocular lens (IOL) to receive FDA approval for presbyopia correction in the summer of 2022. It is a single-piece hydrophobic acrylic monofocal lens, which is placed in the capsular bag. In its center it carries a black circular mask (FilterRing™) with a diameter of 3.23 mm consisting of polyvinylidene fluoride and carbon black nanoparticles. In the center of this mask sits a 1.36 mm wide aperture. Thanks to this pinhole effect the IC-8® serves as an extended-depth-of-focus (EDOF) IOL and can be used in presbyopia correction.This report describes the case of a patient with an IC-8® implant who underwent Nd:YAG laser capsulotomy for posterior capsule opacification (PCO). The post laser checkup showed a dark central optical change within the IOL and the patient described optical phenomena as well as blurred central vision, which is why he received IOL exchange. The explanted IC-8® was sent to the Intermountain Ocular Research Center at the University of Utah for further analysis.
A 56-year-old male underwent cataract surgery with implantation of a non-diffractive EDOF-IOL on the right and the IC-8® small aperture IOL on the left eye. On the left eye, the patient had received penetrating keratoplasty seven years prior to the cataract operation due to posttraumatic corneal scarring. The early checkups after cataract surgery showed a corrected distance visual acuity (CDVA) in the left eye of +0.1 logMAR in the first month. About 5 months after the operation, PCO was first described on the left eye leading to a decrease in visual acuity to +0.4 logMAR (CDVA). Due to PCO, Nd:YAG laser capsulotomy was conducted 5 months after the cataract operation on the left eye. 12 shots were applied at 2.7 mJ. The following appointments showed a continuously reduced visual acuity of +1.3 logMAR (uncorrected) on the left eye and the patient described blurry and 'swirled' central vision. By slightly tilting his head and thus not using the center of his optic axis, he would be able to see sharper. Slit lamp examination showed a small optical change inside the IC-8® IOL not resembling a pit but believed to be a small pocket of air. Due to the ongoing symptoms as well as the reduced VA, the seemingly damaged small aperture IOL was exchanged for a three-piece hydrophobic acrylic monofocal lens, which was also placed in the posterior chamber. The explanted IC-8® was sent to the Intermountain Ocular Research Center at the University of Utah for further analysis. Results from gross and light microscopic analysis showed that the change caused by the Nd:YAG laser application consisted of a localized optical area containing carbon black nanoparticles used for the circular mask within the IOL.
When dealing with PCO and performing Nd:YAG laser capsulotomy in eyes with an IC-8® IOL implant, the laser shots should be applied either inside the aperture or outside of the black circular mask of the IOL. Otherwise, the Nd:YAG laser can lead to bursts of carbon nanoparticles within the IOL which may cause optical phenomena as well as decreased visual acuity possibly resulting in an IOL exchange.
IC-8® Apthera™(美国加利福尼亚州欧文市的AcuFocus Inc.™公司)是首款于2022年夏季获得美国食品药品监督管理局(FDA)批准用于矫正老花眼的小孔径人工晶状体(IOL)。它是一片式疏水丙烯酸单焦点晶状体,植入囊袋内。其中心有一个直径3.23毫米的黑色圆形遮罩(FilterRing™),由聚偏二氟乙烯和炭黑纳米颗粒组成。在这个遮罩的中心有一个宽1.36毫米的小孔。由于这种针孔效应,IC-8®可作为扩展焦深(EDOF)人工晶状体用于矫正老花眼。本报告描述了一例植入IC-8®的患者因后囊膜混浊(PCO)接受Nd:YAG激光囊膜切开术的病例。激光治疗后的检查显示人工晶状体中心出现暗区光学变化,患者描述了视觉现象以及中心视力模糊,因此接受了人工晶状体置换。取出的IC-8®被送往犹他大学山间眼研究中心进行进一步分析。
一名56岁男性接受了白内障手术,右眼植入非衍射EDOF人工晶状体,左眼植入IC-8®小孔径人工晶状体。左眼患者在白内障手术前7年因创伤后角膜瘢痕接受了穿透性角膜移植术。白内障手术后早期检查显示,术后第一个月左眼矫正远视力(CDVA)为+0.1 logMAR。术后约5个月,左眼首次出现PCO,导致视力下降至+0.4 logMAR(CDVA)。由于PCO,左眼在白内障手术后5个月进行了Nd:YAG激光囊膜切开术。以2.7 mJ的能量发射了12次激光。随后的检查显示左眼视力持续下降至+1.3 logMAR(未矫正),患者描述中心视力模糊且有“漩涡状”。通过轻微倾斜头部,即不使用视轴中心,他能看得更清楚。裂隙灯检查显示IC-8®人工晶状体内部有一个小的光学变化,不像一个凹坑,而是被认为是一小团空气。由于症状持续以及视力下降,将看似受损的小孔径人工晶状体更换为一片式疏水丙烯酸单焦点晶状体,同样植入后房。取出的IC-8®被送往犹他大学山间眼研究中心进行进一步分析。大体和光学显微镜分析结果显示,Nd:YAG激光应用引起的变化包括人工晶状体内一个局部光学区域,该区域含有用于圆形遮罩的炭黑纳米颗粒。
在植入IC-8®人工晶状体的眼中处理PCO并进行Nd:YAG激光囊膜切开术时,激光应在人工晶状体的小孔内或黑色圆形遮罩外发射。否则,Nd:YAG激光可导致人工晶状体内的碳纳米颗粒爆发,这可能引起视觉现象以及视力下降,甚至可能导致人工晶状体置换。